Preclinical WebsiteClinical Website

Gray Matter Density in CBD-Control Subjects 

Surface projections of the statistically significant gray matter density differences between CBD and Control subjects

Change in Gray Matter Density in CBD Subjects over 12 months

Change over time within the CBD population over a 12-month period

Difference in Gray Matter Density in PSP-CBD Subjects

Difference in gray matter density in the PSP population compared to the CBD population at the 12 month time point

Surface projections of the statistically significant (FDR-corrected, q=0.05) gray matter density differences between CBD and Control subjects (top), as well the change over time within the CBD population over a 12-month period (middle), and the difference in gray matter density in the PSP population compared to the CBD population at the 12 month time point (bottom).

--:--

The voxelwise gray matter density map at the top illustrates the statistically significant differences in cortical gray matter density between CBD subjects and healthy controls, where the deep blue and purple colors indicate reduced gray matter density. The middle panel shows changes over a 12 month period and highlights the rapid changes apparent in the CBD subjects. The comparisons highlight the reduction in gray matter density throughout the cortex in the CBD subjects, both at baseline compared to controls, as well as the regions changing over 12 months, with distinctly different patterns of cortical atrophy compared to PSP subjects, illustrated in red and yellow voxels in the lower panel.

We use necessary cookies to make our site work. We also use other cookies to help us make improvements by measuring how you use the site or for marketing purposes. You have the choice to accept or reject them all. For more detailed information about the cookies we use, see our Privacy Notice.